Evidence map›Paper›PMID 40419551›Full record

ArticleScientific reports2025

High-fidelity in silico generation and augmentation of TCR repertoire data using generative adversarial networks.

Piotr Religa, Michel-Edwar Mickael, Norwin Kubick, Jarosław Olav Horbańczuk, Nikko Floretes, Mariusz Sacharczuk, Atanas G Atanasov

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Piotr Religa *Department of Medicine, Karolinska Institute, Visionsgatan 18, 171 76, Solna, Sweden. piotr.religa@ki.se.
Michel-Edwar Mickael *Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Postepu 36A, 05-552, Jastrzebiec, Poland. m.mickael@igbzpan.pl.
Norwin KubickDepartment of Biology, Institute of Plant Science and Microbiology, University of Hamburg, Ohnhorststr. 18, 22609, Hamburg, Germany.
Jarosław Olav HorbańczukDepartment of Medicine, Karolinska Institute, Visionsgatan 18, 171 76, Solna, Sweden.
Nikko FloretesCollege of Engineering, Samar State University, University Access Rd, 6700, Catbalogan City, Philippines.
Mariusz SacharczukDepartment of Pharmacodynamics, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1B, 02-091, Warsaw, Poland. m.sacharczuk@igbzpan.pl.
Atanas G AtanasovInstitute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Postepu 36A, 05-552, Jastrzebiec, Poland. Atanas.Atanasov@dhps.lbg.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Engineered T-cell receptor (eTCR) systems rely on accurately generated T-cell receptor (TCR) sequences to enhance immunotherapy predictability and efficacy. The most variable and crucial part of the TCR receptor is the CDR3 sequence region. Current methods for generating CDR3 sequences, including motif-based and Markov models, struggle to generate reliable, diverse, and novel TCR sequences. In this study, we present the first application of Generative Adversarial Networks (GANs) for producing biologically reliable CDR3 sequences, using Long Short-Term Memory (LSTM) networks and LeakyReLU-based GANs. Our results show that LSTM models generate more diverse sequences with higher accuracy, lower discriminator loss, and higher AUC compared to LeakyReLU. However, LeakyReLU provides greater stability with a lower generator loss, achieving a total Pearson correlation score of over 0.9. Both models demonstrate the ability to produce highly realistic TCR sequences, as validated by t-SNE clustering, frequency distribution analysis, TCRd3 BLAST analysis, and in silico docking. These findings highlight the potential of GANs as a powerful tool for generating synthetic yet biologically relevant TCR sequences, a crucial step toward improving eTCR-based therapies. Further refinement of amino acid frequency distributions and clinical validation will enhance their applicability for therapeutic purposes.

Indexed as

Generative Adversarial NetworksReceptors, Antigen, T-CellComplementarity Determining RegionsComputer SimulationHumansComplementarity Determining RegionsReceptors, Antigen, T-Cell

Identifiers

PMID40419551
PMCPMC12106775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.